Trials / Unknown
UnknownNCT04176887
Levetiracetam Versus Phenytoin in Management of Pediatric Status Epilepticus
Levetiracetam Versus Phenytoin in Management of Pediatric Status Epilepticus: a Randomized Clinical Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 30 Days – 18 Years
- Healthy volunteers
- Not accepted
Summary
The study will be conducted on 60 children suffering from status epilepticus who will be admitted to Pediatric Neurology Unit and Pediatric ICU of Tanta Hospital University.
Detailed description
The aim of this work is to compare the efficacy of Levetireacetam and Phenytoin in management of pediatric status epilepticus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levetiracetam Injection | The levetiracetam dose is 20- 40 mg/kg by intravenous infusion over 15 minute, a rate of 2-5 mg/kg/minute diluted in 100 ml with 0.9% sodium chloride as a single dose. |
| DRUG | Phenytoin Injection | Phenytoin dose is 20-40 mg/kg/min by intravenous infusion over 30 minute, diluted with 0.9% sodium chloride to a maximum concentration of 10 mg/ml. |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2020-02-01
- Completion
- 2020-08-01
- First posted
- 2019-11-25
- Last updated
- 2019-11-25
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04176887. Inclusion in this directory is not an endorsement.